 |
인쇄하기
취소
|
Six clopidogrel makers strives to get national health insurance reimbursement
The nation's six clopidogrel producers have retried to get their products listed in health insurance allowance since their failure last February.
The six drug makers include Kwangdong Pharm, Halim Pharm, Pacific Pharm, Korea Colmar Pharm, Hanall Pharm and Reyon Pharm.
The Health Insurance Review Agency is scheduled to evaluate the effectiveness of these medicines in order to decide whethe...
The six drug makers include Kwangdong Pharm, Halim Pharm, Pacific Pharm, Korea Colmar Pharm, Hanall Pharm and Reyon Pharm.
The Health Insurance Review Agency is scheduled to evaluate the effectiveness of these medicines in order to decide whethe...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.